Details For Selected Brain Tumor Treatment

Sponsored By

Cleveland Clinic Brain Tumor and Neuro-Oncology Center

Please Click On The Above Banner For More Details

Back to New Treatments List


		Treatment Name:		Phase I Trial of Aflibercept (VEGF Trap)with Radiation Therapy and Concomitant and Adjuvant Temozolomide in Patients With Malignant Gliomas

		Phase:		Phase 1/2

		Treatment ID#:		1815 NABTC 07-01

		Age Group:		Adults Only

		Min Karnofsky Score:		60: Requires occasional assistance but is able to care for most of own needs

		Conditions:		Prior Surgery is Allowed Prior Radiation is Sometimes Allowed Prior Chemotherapy is Sometimes Allowed

		Last Updated:		10/27/2008

		Tumor Types:		Anaplastic Astrocytoma Glioblastoma Multiforme Gliosarcoma Mixed Glioma Oligodendroglioma High Grade


		Comments:		VEGF Trap is a specific antagonist that binds and inactivates circulating VEGF in the blood stream and in the extravascular space. Treatment with VEGF Trap is well tolerated and resulted in evaluable response in a significant number of patients when used as a single agent, and constitutes the rationale for combination with temozolomide and radiation therapy following debulking surgery.

		Treatment Type:		Chemotherapy

		Contact:		John G. Kuhn Pharm, FCCP University of Texas Health Science Center at San Antonio San Antonio, TX 78284-6220 USA Phone: 210-567-8355 Fax: E-mail: Website:

Last updated refers to the date when our listing for each treatment was last updated.
ID is a combination of our internal ID and the official ID for the trial, if any.
Min Karnofsky is a general guide to how well you have to function to use this treatment

Translate this pageMicrosoftÂ® Translator

Copyright (c) 1993 - 2009 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740

Website Design By